Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation
(Hinzugefügt: 18.11.2022 um 14:45 Uhr)
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
(Hinzugefügt: 06.06.2022 um 09:12 Uhr)
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India
(Hinzugefügt: 18.12.2021 um 14:55 Uhr)
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
(Hinzugefügt: 30.11.2021 um 16:14 Uhr)
Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India
(Hinzugefügt: 27.07.2021 um 19:24 Uhr)
COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion
(Hinzugefügt: 27.05.2021 um 15:43 Uhr)